The founders of Metsera have a battle to buy their company. It would be their second time striking deal gold.

Oral GLP-1 weight loss pills could replace injections by March 2026 at $150 monthly, Medicare chief Dr. Mehmet Oz predicted ...

Novo Nordisk’s oral semaglutide 25 mg achieved up to 16.6% weight loss in a landmark study, rivaling injectable Wegovy. The ...

The idea of supplements replacing a balanced diet has become increasingly popular, with many believing that popping pills can give them all the nutrients they need ...

New study has discovered a groundbreaking technology that is showing remarkable success in significantly reducing bad ...

Eli Lilly said on Thursday its experimental weight-loss pill met most criteria for the U.S. Food and Drug Administration's ...

Those taking the drug, which contains a substance banned in many other countries, are experiencing severe side effects.

Molecule is claimed to be made from "natural ingredients" such as dandelion root and fennel seed, but investigations tell a ...

New versions of drugs like Wegovy, Ozempic, Mounjaro and Zepbound, including pills, will be easier to take, more effective ...

Wegovy-maker Novo Nordisk presented new data on Wednesday showing its experimental weight-loss pill improved blood sugar ...

Novo Nordisk and Eli Lilly said they've agreed to sell their blockbuster drugs Wegovy and Zepbound at a discount.

Experts say the deal to lower the cost of the drugs is ambitious, but left some with more questions than answers.